Nexgel (NXGL) Revenue Growth (3y) (2021 - 2025)
Nexgel (NXGL) Revenue Growth (3y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | 18.10% |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | -0.75% |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | 4.80% |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | - |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | 8.62% |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | 4.99% |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | -0.07% |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | 7.22% |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | 3.32% |
| 10 | Nexgel | 3.43 Mn | 1.63 Mn | 819,000.00 | 74.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 74.74% |
| Sep 30, 2025 | 72.86% |
| Jun 30, 2025 | 72.59% |
| Mar 31, 2025 | 92.07% |
| Dec 31, 2024 | 78.69% |
| Sep 30, 2024 | 106.27% |
| Jun 30, 2024 | 51.15% |
| Mar 31, 2024 | 68.00% |
| Dec 31, 2023 | 120.45% |
| Sep 30, 2023 | 71.51% |
| Jun 30, 2023 | 134.07% |
| Mar 31, 2023 | 37.21% |
| Dec 31, 2022 | 43.86% |
| Sep 30, 2022 | 25.55% |
| Mar 31, 2022 | 45.33% |
| Dec 31, 2021 | 4.96% |
| Sep 30, 2021 | -1.26% |